Telescope Innovations Corp. News Releases

Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026

Mon, 13 Apr 2026 18:00:00 -0400

Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6...

Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation

Mon, 23 Mar 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to announce that Dr. Joel M. Hawkins has expanded his consulting role with Telescope. Dr. Hawkins is an industry-wide authority in automating complex chemistry workflows and enabling the...

Telescope Innovations and AGI SDA Launch Technology Development Collaboration

Mon, 16 Mar 2026 08:00:00 -0400

The chemistry technology companies aim to develop a next-generation chemical reactor for automated labs Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries, with established leadership in sampling systems for monitoring chemical and biological processes. The Company is...

Telescope Strengthens Investor Communications Strategy

Thu, 12 Mar 2026 08:30:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries,has rescoped its previously announced digital marketing agreement dated September 19, 2025, with Gold Standard Media, LLC ("GSM") and its affiliates. In connection with the reduction in scope GSM has refunded the Company $300,000...

Telescope Innovations Installs Second Self-Driving Lab at Pfizer

Mon, 23 Feb 2026 08:00:00 -0500

Installation of second Physical AI platform positions Telescope Innovations to successfully address the rapidly expanding SDL market Vancouver, British Columbia--(Newsfile Corp. - February 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, is pleased to announce the installation of its second Self-Driving Laboratory ("SDL") at Pfizer,...

Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026

Fri, 30 Jan 2026 19:28:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - January 30, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended November 30, 2025 (Q1). The Company generated revenues of $2.7 million during this period, driven by continued market adoption of its flagship product, DirectInject-LC™,...

Telescope Innovations Expands Lithium Development Infrastructure and Achieves Key Material Validation Milestones

Tue, 27 Jan 2026 08:00:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - January 27, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a leader in Physical AI, Self-Driving Laboratories, and other enabling technology to support autonomous laboratory infrastructure. The Company is pleased to provide an update on the progress of its lithium processing portfolio. Our focus remains on securing a sustainable, on-shore supply of critical battery materials through our...

Telescope Innovations Plans Expansion of DirectInject-LC(TM) Technology Ecosystem to Fuel the Physical AI Revolution

Tue, 20 Jan 2026 08:00:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - January 20, 2026) - Telescope Innovations Corp., (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), is a leader in Physical AI, Self-Driving Laboratories, and enabling technology supporting autonomous laboratory infrastructure. The Company is pleased to provide a look at its planned 2026 technology development pipeline, which aligns with its Self-Driving Lab (SDL) architecture for autonomous chemistry R&D. Building on the...

Telescope Innovations Outlines Global Market Opportunity for Self-Driving Labs and the Rising Adoption of Physical AI

Mon, 05 Jan 2026 08:00:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - January 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to provide a strategic update regarding the accelerating commercial adoption of Self-Driving Labs (SDLs) and the global expansion of Physical AI.This update follows the Company's recent successful deployment of a pharmaceutical SDL for...

Telescope Grants Stock Options, RSUs and Settles Debt with Shares

Wed, 31 Dec 2025 08:00:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries announces that it has authorized the grant of incentive stock options (the "Options"), restricted share units (the "RSUs") as well as the issuance of common shares to settle outstanding fees owed to its CEO.Stock Option...